Pharma Day will gather researchers with an outstanding scientific experience in experimental and clinical oncology, and biopharmaceutical companies from all over Europe. Also, top level scientists in the field of molecular oncology will be presenting their results on new therapies and diagnostic tools.
We have already confirmed the participation of Cezary Scibiorski, Country Medical Director of Bristol Myers Squibb; Magda Chlebus, Director of Science Policy at EFPIA; Robert Verhagen, CEO of Helix Biopharma; Krzysztof Wojciechowski, Head of Strategy at INFARMA, the Employers’ Union of Innovative Pharmaceutical Companies; Patryk Mikucki, Hub Director, Study Management & Operations, AstraZeneca; Alina Pszczolkowska, Global Director Site Managment&Monitoring, AstraZeneca; Henryk Gruza, R&D Division Director, Polpharma.
Receive the Funding Newswire each Tuesday, our Policy Bulletin each Thursday, and news about bridging Europe’s east-west innovation gap twice a month in The Widening. 
A unique international forum for public research organisations and companies to connect their external engagement with strategic interests around their R&D system.
